Effects of Backward Gait on Sand on Improving the Gait Parameters of Patients With Chronic Stroke.

May 31, 2018 updated by: faizan kashoo, PT, Majmaah University

Effects of Backward Gait on Sand on Improving the Gait Parameters of Patients With Chronic Stroke: a Randomized Controlled Trial

Gait training in stroke is a complex process of motor learning although restoring patients ability to walk would not prepare the individual with the challenges faced in the real environment. The aim is not simply walking in controlled environment, but to achieve dynamic walking. Dynamic walking is the ability of an individual to adjust to the changing surfaces and terrains. thereby returning to achieve active participation in the community. Hence, recovery of walking ability is the primary goal when planning treatment for patients with stroke.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Riyadh
      • Al Majma'ah, Riyadh, Saudi Arabia, 11952
        • Recruiting
        • King Khalid Hospital
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Faizan Z Kashoo, Masters
        • Principal Investigator:
          • Mazen M Alqahtani, PhD
        • Sub-Investigator:
          • Shaik A Rahim, PhD
        • Sub-Investigator:
          • Dana A Yahya, PhD
        • Sub-Investigator:
          • Abdulaziz Alkathiry, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  • Had experienced stroke for the first time.
  • Unilateral involvement.
  • Demonstrate motor stage 3 or 4 on Brunnstrom motor recovery.
  • Able to walk 12 m with or without assistive devices.
  • Medically stable.
  • Able to follow simple commands.

Exclusion criteria:

  • Patient exhibits comorbid disease other than stroke that may affect gait.
  • Any conditions contra indicated to exercises
  • Any other cardio-pulmonary or orthopedic disorders that affects walking ability of the participant.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: QUADRUPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Group 1
forward walking on leveled surface
the patient will be walking backwards on sand with therapist standing close to support in case of fall.
Other Names:
  • forward walking on sand
ACTIVE_COMPARATOR: Group 2
forward walking on sand.
the patient will be walking backwards on sand with therapist standing close to support in case of fall.
Other Names:
  • forward walking on sand
EXPERIMENTAL: Group 3
Backward walking on leveled surface
the patient will be walking backwards on sand with therapist standing close to support in case of fall.
Other Names:
  • forward walking on sand
ACTIVE_COMPARATOR: Group 4
Backward walking on sand.
the patient will be walking backwards on sand with therapist standing close to support in case of fall.
Other Names:
  • forward walking on sand

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait velocity (m/s)
Time Frame: 10-15 mins
Measured by Stride Analyser
10-15 mins
Cadence (Number of steps per min)
Time Frame: 10-15 mins
Measured by stride Analyser
10-15 mins
Stride length in meters
Time Frame: 10-15 mins
Measured by stride Analyser
10-15 mins
Gait cycle in seconds
Time Frame: 10-15 mins
Measured by stride Analyser
10-15 mins

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Barthel index
Time Frame: 45 Mins
ADL
45 Mins

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 12, 2017

Primary Completion (ANTICIPATED)

June 20, 2018

Study Completion (ANTICIPATED)

July 21, 2018

Study Registration Dates

First Submitted

April 9, 2018

First Submitted That Met QC Criteria

April 16, 2018

First Posted (ACTUAL)

April 18, 2018

Study Record Updates

Last Update Posted (ACTUAL)

June 1, 2018

Last Update Submitted That Met QC Criteria

May 31, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Stroke Patients

IPD Sharing Time Frame

3 months

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Stroke

Clinical Trials on Backward walking on sand

Subscribe